Collectively, our findings not only explained the poorer prognosis observed in aged pancreatic cancer patients but also revealed that MMA can promote LOXL2 expression in PSCs, increasing linear ECM alignment, and accelerate the progression of PDAC (Graphical Abstract 1). Here, LOXL2 is linked to familial pancreatic carcinoma.